期刊文献+

66例幽门螺杆菌感染者耐药性分析 被引量:12

Analysis on Antibiotic Resistance of Helicobacter pylori in Liaocheng
下载PDF
导出
摘要 目的通过对66例幽门螺杆菌感染(HP)者临床分离菌株的培养和药敏试验,分析幽门螺杆菌对常用抗生素的耐药性,为临床选用抗生素治疗HP提供依据。方法采用Kiby-bauer法检测HP临床分离菌株对阿莫西林、甲硝唑、克拉霉素、左氧氟沙星、四环素、呋喃唑酮的耐药率,并分析性别、年龄及不同疾病对耐药率的影响。结果幽门螺杆菌对阿莫西林、甲硝唑、克拉霉素、左氧氟沙星、四环素、呋喃唑酮的耐药率分别为4.0%、32.0%、10.0%、24.0%和6.0%、0%;甲硝唑在女性与男性中的耐药率存在差异(P<0.05)。不同年龄和不同临床疾病患者,HP对各抗生素耐药率比较无显著性差异(P>0.05)。结论本地区幽门螺杆菌对呋喃唑酮、阿莫西林、四环素、克拉霉素的敏感性较高,对甲硝唑、左氧氟沙星的耐药耐药性较高;女性甲硝唑耐药高于男性,各抗生素耐药与患者年龄和疾病种类无关。 Objective To analyze the antibiotic resistance of Helicobacter pylori (HP)by cultivation and drug sensitive test of clinical isolated strains in Liaocheng. Methods To observe antimicrobial susceptibility of HP strains to Amoxicilin, Metronidazole, Clarithromycin, levofloxacin, tetracycline and furazolidone by Kirby-Bauer disk diffusion test. Results The percentage of resistant strains were as follows :4.0% to amoxicillin,32.0% to metronidazole,10.0% to clarithromycin,24.0% to levofloxacin,6.0% to tetracycline and 0% to furazolidone ;Resistance of HP to metronidazole was different between man and woman( P 〈 0.05 ). Resistance to each agent was the same in different age and stomach diseases( P 〉 0.05 ). Conclusion Susceptibility of HP to furazolidone, amoxicillin, Tetracycline and clarithromycin are high. However, resistance to metronidazole and levofloxacin are high;Resistance of HP to Metronidazole is higher in woman than that in man. There are no relationships between resistance and different age and stomach diseases.
出处 《临床内科杂志》 CAS 2008年第11期747-749,共3页 Journal of Clinical Internal Medicine
关键词 幽门螺杆菌 抗生素 耐药性 Helicobacter pylori Antibiotic Resistance
  • 相关文献

参考文献11

二级参考文献36

  • 1贾博琦,中华消化杂志,1995年,15卷,增刊,1页
  • 2陈寿坡,现代胃肠病学,1994年
  • 3张万岱,幽门螺杆菌与胃十二指肠疾病,1992年
  • 4Van der Hulst RW, Rauws EA, Koycu B, et al. Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study. Gastroenterology, 1997, 113: 1082-1086.
  • 5Malfertheiner P, Bayerdorffer E, Diete U, et al. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer. Aliment Pharmacol Ther, 1999, 13: 703-712.
  • 6Bermejo F, Bioxeda D, Gisbert JP, et al. Effects of Helicobacter pylori after eradication on the recurrence of gastric ulcer during a 12-month follow up. Med Clin (Barc), 2000, 115: 201-204.
  • 7International Agency for Research on Cancer. Schistosomes, live flukes and Helicobacter pylori. LARC monographs on the evaluation on carcinogenic risks to humans. Vo161. Lyon: LARC, 1994.
  • 8Wotherspoon AC, Ortiz-Hidgo C, Falzon MR. Helicobacter pylori - associated gastritis and primary B - cdll gastric lymphoma. Lancet, 1991, 338: 1175-1176.
  • 9Eide S, Stolte M, Fisher, et al. Helicobacter pylori gastritis non - Hodgkin's lymphoma. J Ckin Pathol, 1994, 47: 436-439.
  • 10Wotherspoon AC, Dogliani C, Diss TC, et al. Regression of primary low grade B - cell gastric lymphoma of mucosa - associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet, 1993, 342: 4575-4577.

共引文献279

同被引文献65

  • 1隋小妹.含铋剂四联方案治疗幽门螺杆菌阳性疗效观察[J].中国误诊学杂志,2009,9(3). 被引量:6
  • 2元刚,陈旻湖.幽门螺杆菌根除失败的补救措施[J].临床消化病杂志,2006,18(2):70-72. 被引量:31
  • 3吕琳,梅浙川.幽门螺杆菌对大环内酯类抗生素的耐药机制及耐药性检测[J].中国抗生素杂志,2007,32(1):6-10. 被引量:2
  • 4田雨,王蔚虹,胡伏莲.中国幽门螺杆菌感染治疗共识意见[J].中国医药导刊,2007,9(2):104-105. 被引量:75
  • 5成虹 胡伏莲.幽门螺杆菌耐药机制.中华消化杂志,2003,23(9):557-559.
  • 6Cheon JM,Kin N,Lee DH,et al.Trial of moxifloxacin-containing triple therapy after initial and second-line treatment failtures for helicobacter pylori infection[J].Korean J Castroenteral,2005,45:111-117.
  • 7Kanellakopoulou K,Sarafis P,Galani I,et al.In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of psoudomonas aeruginosa[J].Int J Antimicrob Agents,2008,32(1):33-39.
  • 8Sahm DF,Washington JA.Antibacterial Susceptibility tests,dilution methods,Manual of clinical Microbiology[M] 6th ed,N W washington US Society for Microbiology,1995:11-17.
  • 9National Committee for clinical Laboratory Standards.Performance Standards for Antimicrobial Susceptibility testing[S].Approved Standard,2002:M100-S12.
  • 10Bago,P,Vcev A,Tomic M,et al.High eradication rate of H,pylori with moxifloxacin-base treatment:a randomiged controlled trial[J].wien Klin wochenschr,2007,119(11-12):372.

引证文献12

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部